Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM

Human Brain Mapping

Volumn 30, Issue 9, 2009, Pages 2852-2861

  Bodini, Benedetta ^a,b   Khaleeli, Zhaleh ^a   Cercignani, Mara ^a,c   Miller, David H ^a   Thompson, Alan J ^a   Ciccarelli, Olga ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Diffusion tensor imaging; Normal appearing white matter; Primary progressive multiple sclerosis; Tract based spatial statistics; Voxel based morphometry

Indexed keywords

ADULT; ANISOTROPY; ARTICLE; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISABILITY; DISEASE ASSOCIATION; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; MALE; MORPHOMETRICS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TRACT BASED SPATIAL STATISTICS; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGE OF ONSET; BRAIN; BRAIN MAPPING; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NERVE FIBERS, MYELINATED; NEURAL PATHWAYS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WALLERIAN DEGENERATION;

EID: 68549139612     PISSN: 10659471     EISSN: None     Source Type: Journal    
DOI: 10.1002/hbm.20713     Document Type: Article

References (50)

1. Ashburner J, Friston KJ (2000): Voxel-based morphometry-the methods. Neuroimage 11:805-821.
2. Audoin B, Au Duong MV, Ranjeva JP, Ibarrola D, Malikova I, Confort-Gouny S, Soulier E, Viout P, Ali-Chérif A, Pelletier J, Cozzone PJ (2005): Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp 24:216-228.
3. Basser PJ, Mattiello J, LeBihan D (1994): MR diffusion tensor spectroscopy and imaging. Biophys J 66:259-267.
4. Beaulieu C, Does MD, Snyder RE, Allen PS (1996): Changes in water diffusion due to Wallerian degeneration in peripheral nerve. Magn Reson Med 36:627-631.
5. Bo L, Geurts JJ, van der Valk P, Polman C, Barkhof F (2007): Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 64:76-80.
6. Cader S, Johansen-Berg H, Wylezinska M, Palace J, Behrens TE, Smith S, Matthews PM (2007): Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis. Neuroimage 36:19-27.
7. Charil A, Dagher A, Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC (2007): Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability. Neuroimage 34:509-517.
8. Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, Barker GJ, Parker GJ, Thompson AJ, Miller DH (2001): Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 56:926-933.
9. Ciccarelli O, Werring DJ, Barker GJ, Griffin CM, Wheeler-Kingshott CA, Miller DH, Thompson AJ (2003): A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence of Wallerian degeneration. J Neurol 250:287-292.
10. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E (1999): Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122:871-882.
11. De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM (2003): Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 60:1157-1162.
12. Della Nave R, Ginestroni A, Tessa C, Salvatore E, Bartolomei I, Salvi F, Dotti MT, De Michele G, Piacentini S, Mascalchi M (2008): Brain white matter tracts degeneration in Friedreich ataxia. An in vivo MRI study using tract-based spatial statistics and voxel-based morphometry. Neuroimage 40:19-25.
13. Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J, James S, Voets N, Watkins K, Matthews PM, James A (2007): Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 130:2375-2386.
14. Filippi M, Rovaris M, Rocca MA (2004): Imaging primary progressive multiple sclerosis: The contribution of structural, metabolic, and functional MRI techniques. Mult Scler 10(Suppl 1):S36-S44 (review).
15. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001): A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21-36.
16. Hobart J, Freeman J, Thompson AJ (2000): Kurtzke scales revisited: The application of psychometric methods to clinical intuition. Brain 123:1027-1040.
17. Ingle GT, Stevenson VL, Miller DH, Thompson AJ (2003): Primary progressive multiple sclerosis: A 5-year clinical and MR study. Brain 126:2528-2536.
18. Jenkinson M, Smith S (2001): A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143-156.
19. Jones DK, Horsfield MA, Simmons A (1999): Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 42:515-525.
20. Khaleeli Z, Sastre-Garriga J, Ciccarelli O, Miller DH, Thompson AJ (2007a): Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 78:1076-1082.
21. Khaleeli Z, Cercignani M, Audoin B, Ciccarelli O, Miller DH, Thompson AJ (2007b): Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 37:253-261.
22. Kurtzke JF (1983): Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33:1444-1452.
23. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005): Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705-2712.
24. Leary SM, Silver NC, Stevenson VL, Barker GJ, Miller DH, Thompson AJ (1999): Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis. Mult Scler 5:313-316.
25. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002): Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain 125:1676-1695.
26. Morgen K, Sammer G, Courtney SM, Wolters T, Melchior H, Blecker CR, Oschmann P, Kaps M, Vaitl D (2006): Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 30:891-898.
27. Nichols TE, Holmes AP (2002): Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum Brain Mapp 15:1-25.
28. Pelletier D, Nelson SJ, Oh J, Antel JP, Kita M, Zamvil SS, Goodkin DE (2003): MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy. J Neurol Neurosurg Psychiatry 74:950-952.
29. Pirko I, Lucchinetti CF, Sriram S, Bakshi R (2007): Gray matter involvement in multiple sclerosis. Neurology 68:634-642 (review).
30. Plummer D (1992): Disp image: A display and analysis tool for medical images. Rev Neuroradiol 5:489-495.
31. Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C (2006): Grey matter loss in relapsing-remitting multiple sclerosis: A voxel-based morphometry study. Neuroimage 29:859-867.
32. Ramió-Torrentà L, Sastre-Garriga J, Ingle GT, Davies GR, Ameen V, Miller DH, Thompson AJ (2006): Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: A tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 77:40-45.
33. Rovaris M, Bozzali M, Santuccio G, Ghezzi A, Caputo D, Montanari E, Bertolotto A, Bergamaschi R, Capra R, Mancardi G, Martinelli V, Comi G, Filippi M (2001): In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124:2540-2549.
34. Rovaris M, Bozzali M, Iannucci G, Ghezzi A, Caputo D, Montanari E, Bertolotto A, Bergamaschi R, Capra R, Mancardi GL, Martinelli V, Comi G, Filippi M (2002): Assessment of normalappearing white and gray matter in patients with primary progressive multiple sclerosis: A diffusion-tensor magnetic resonance imaging study. Arch Neurol 59:1406-1412.
35. Rovaris M, Judica E, Gallo A, Benedetti B, Sormani MP, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Mancardi G, Bergamaschi R, Martinelli V, Comi G, Filippi M (2006): Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 129:2628-2634.
36. Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hawkes DJ (1999): Nonrigid registration using free-form deformations: Application to breast MR images. IEEE Trans Med Imaging 18:712-721.
37. Sastre-Garriga J, Ingle GT, Chard DT, Ramio-Torrenta L, Miller DH, Thompson AJ (2004): Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage 22:353-359.
38. Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ (2005): Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 62:569-573.
39. Schmierer K, Wheeler-Kingshott CA, Boulby PA, Scaravilli F, Altmann DR, Barker GJ, Tofts PS, Miller DH (2007): Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 35:467-477.
40. Sepulcre J, Sastre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thompson AJ (2006): Regional gray matter atrophy in early primary progressive multiple sclerosis: A voxel-based morphometry study. Arch Neurol 63:1175-1180.
41. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004): Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208-S219.
42. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006): Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487-1505.
43. Smith SM, Johansen-Berg H, Jenkinson M, Rueckert D, Nichols TE, Miller KL, Robson MD, Jones DK, Klein JC, Bartsch AJ, Behrens TE (2007): Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2:499-503.
44. Symms MR, Barker GJ, Franconi F, Clark CA (1997): Correction of eddy current distortions in diffusion-weighted echo-planar images with a two dimensional registration technique. Proc Int Soc Magn Reson Med 1997:1723.
45. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI (2000): Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol 47:831-835.
46. Thompson AJ (2004): Overview of primary progressive multiple sclerosis (PPMS): Similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Mult Scler 10(Suppl 1):S2-S7.
47. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, BöL (1998): Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
48. Tsunoda I, Kuang LQ, Libbey JE, Fujinami RS (2003): Axonal injury heralds virus-induced demyelination. Am J Pathol 162:1259-1269.
49. Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, Castelijns JA (2006): Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 23:628-636.
50. Wheeler-Kingshott CA, Boulby PA, Symms MR, Barker GJ (2002): Optimised cardiac gating for high-resolution whole-brain DTI on a standard scanner. Proc Int Soc Magn Reson Med 2002: 1118.